Wall Street brokerages forecast that Danaher Co. (NYSE:DHR) will post $0.93 earnings per share for the current fiscal quarter, Zacks reports. Eight analysts have provided estimates for Danaher’s earnings, with the highest EPS estimate coming in at $0.94 and the lowest estimate coming in at $0.91. Danaher reported earnings per share of $0.85 during the same quarter last year, which suggests a positive year-over-year growth rate of 9.4%. The company is scheduled to issue its next earnings report on Thursday, April 19th.
According to Zacks, analysts expect that Danaher will report full-year earnings of $4.37 per share for the current financial year, with EPS estimates ranging from $4.30 to $4.50. For the next financial year, analysts forecast that the company will report earnings of $4.75 per share, with EPS estimates ranging from $4.64 to $4.91. Zacks’ earnings per share averages are an average based on a survey of sell-side research analysts that follow Danaher.
Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, January 30th. The conglomerate reported $1.19 EPS for the quarter, topping analysts’ consensus estimates of $1.16 by $0.03. Danaher had a net margin of 13.60% and a return on equity of 11.36%. The business had revenue of $5.09 billion for the quarter, compared to analysts’ expectations of $4.97 billion. During the same quarter last year, the company earned $1.05 EPS. The business’s revenue was up 10.9% on a year-over-year basis.
A number of brokerages have recently issued reports on DHR. Cowen reiterated a “buy” rating and set a $110.00 target price on shares of Danaher in a research report on Tuesday, January 30th. Credit Suisse Group increased their target price on Danaher from $99.00 to $105.00 and gave the company an “outperform” rating in a research report on Wednesday, January 31st. Royal Bank of Canada reiterated a “hold” rating and set a $98.00 target price on shares of Danaher in a research report on Wednesday, January 31st. Stifel Nicolaus increased their target price on Danaher from $110.00 to $115.00 and gave the company a “buy” rating in a research report on Wednesday, January 31st. Finally, Morgan Stanley increased their target price on Danaher from $103.00 to $110.00 and gave the company an “overweight” rating in a research report on Wednesday, January 31st. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $100.68.
In related news, EVP William K. Daniel sold 131,066 shares of the firm’s stock in a transaction dated Friday, February 2nd. The stock was sold at an average price of $102.05, for a total transaction of $13,375,285.30. Following the completion of the sale, the executive vice president now directly owns 270,523 shares of the company’s stock, valued at approximately $27,606,872.15. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Angela S. Lalor sold 42,988 shares of the firm’s stock in a transaction dated Friday, February 2nd. The stock was sold at an average price of $102.29, for a total value of $4,397,242.52. Following the sale, the senior vice president now directly owns 82,008 shares of the company’s stock, valued at $8,388,598.32. The disclosure for this sale can be found here. Insiders have sold a total of 237,043 shares of company stock valued at $24,194,886 over the last three months. Corporate insiders own 12.20% of the company’s stock.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Envestnet Asset Management Inc. grew its position in Danaher by 4.2% in the 4th quarter. Envestnet Asset Management Inc. now owns 160,706 shares of the conglomerate’s stock valued at $14,917,000 after acquiring an additional 6,547 shares in the last quarter. CNB Bank acquired a new position in Danaher in the 4th quarter valued at about $116,000. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its position in Danaher by 11.7% in the 4th quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 253,593 shares of the conglomerate’s stock valued at $23,539,000 after acquiring an additional 26,584 shares in the last quarter. Sawtooth Solutions LLC acquired a new position in Danaher in the 4th quarter valued at about $308,000. Finally, HM Payson & Co. grew its position in shares of Danaher by 2.6% during the fourth quarter. HM Payson & Co. now owns 213,314 shares of the conglomerate’s stock worth $19,800,000 after buying an additional 5,348 shares in the last quarter. 77.05% of the stock is owned by institutional investors.
Shares of Danaher (DHR) traded up $0.89 during trading hours on Wednesday, hitting $97.74. The stock had a trading volume of 298,306 shares, compared to its average volume of 2,726,023. Danaher has a 52-week low of $78.97 and a 52-week high of $104.82. The stock has a market cap of $67,946.36, a price-to-earnings ratio of 27.67, a price-to-earnings-growth ratio of 2.05 and a beta of 1.04. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.39.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Thursday, March 29th will be given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.65%. This is an increase from Danaher’s previous quarterly dividend of $0.14. Danaher’s dividend payout ratio (DPR) is presently 15.86%.
TRADEMARK VIOLATION NOTICE: “Danaher Co. (DHR) Expected to Announce Earnings of $0.93 Per Share” was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another publication, it was illegally stolen and republished in violation of international trademark & copyright law. The correct version of this news story can be read at https://www.dispatchtribunal.com/2018/02/21/danaher-co-dhr-expected-to-announce-earnings-of-0-93-per-share.html.
Danaher Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Get a free copy of the Zacks research report on Danaher (DHR)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.